Revenue Recognition and Accounts Receivable (Tables)

9 Months Ended

Sep. 30, 2022

Revenue Recognition and Accounts Receivable

Schedule of composition of net revenues by payor type and core service lines

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022			2021	2022		2021
Insurance	$	465,625	$	399,748	$	1,322,694	$	1,061,627
Government		198,841		180,511		576,829		491,564
Patient pay		92,029		73,034		290,789		199,238
Net revenue	$	756,495	$	653,293	$	2,190,312	$	1,752,429

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022			2021	2022		2021
Net sales revenue:
Sleep	$	198,206	$	173,359	$	585,234	$	465,372
Diabetes		169,075		134,228		482,693		352,559
Supplies to the home		47,793		42,441		131,539		126,479
Respiratory		9,734		6,228		25,770		25,003
HME		29,463		29,919		89,828		82,588
Other		58,252		45,996		166,068		98,032
Total net sales revenue	$	512,523	$	432,171	$	1,481,132	$	1,150,033
Net revenue from fixed monthly equipment reimbursements:
Sleep	$	72,423	$	62,755	$	196,022	$	177,199
Diabetes		4,211		3,722		12,191		9,791
Respiratory		130,618		117,918		392,063		312,900
HME		25,482		26,043		76,754		70,854
Other		11,238		10,684		32,150		31,652
Total net revenue from fixed monthly equipment reimbursements	$	243,972	$	221,122	$	709,180	$	602,396
Total net revenue:
Sleep	$	270,629	$	236,114	$	781,256	$	642,571
Diabetes		173,286		137,950		494,884		362,350
Supplies to the home		47,793		42,441		131,539		126,479
Respiratory		140,352		124,146		417,833		337,903
HME		54,945		55,962		166,582		153,442
Other		69,490		56,680		198,218		129,684
Total net revenue	$	756,495	$	653,293	$	2,190,312	$	1,752,429